The COVID 19 disease causes significant morbidity and mortality amongst people with diabetes. The supraphysiological doses of steroid regimen recommended by World Health Organisation(WHO) may exacerbate hyperglycemia in individuals with diabetes, unmask diabetes in the population at risk and precipitate acute complications like diabetic ketoacidosis(DKA) and hyperglycemic hyperosmolar state(HHS). Hyperglycemia increases the incidence and severity of COVID-19 infection, prolonged hospital and ICU stay, contributes to poor disease outcomes and is associated with higher mortality. An appropriate management of in-hospital and post discharge hyperglycemia is the need of the hour. Thorough knowledge of Diabetes will give you a better understanding of this topic and enable you to manage patients better.
The “Fellowship in Diabetes Mellitus” course is the final step in becoming a diabetes expert and addresses the management of diabetic complications and the treatment of diabetes in special populations, permitting you to administer the optimum care to complicated cases. The experience of practical training in a leading corporate hospital guided by expert diabetologists gives you a much-needed clinical experience. This course is designed in collaboration with the Royal Liverpool Academy and incorporates a blended learning design.